secwatch.observer — SEC 8-K summary
======================================

Issuer:     Longeveron Inc. (LGVN)
CIK:        0001721484
Form:       8-K
Filed at:   2025-08-11T23:59:59+00:00
Accession:  0001213900-25-074318
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Longeveron closes $5.0M public offering (up to $17.5M with warrants) for laromestrocel development
--------------------------------------------------------------------------------

- Gross proceeds $5.0M upfront from offering of ~5.88M shares/pre-funded warrants and 14.7M short-term warrants at $0.85 combined price.
- Potential additional $12.5M if short-term warrants (exercisable at $0.85, 24-month term) are fully cash-exercised.
- Proceeds to fund clinical/regulatory development of laromestrocel for HLHS, Alzheimer's, pediatric DCM, and BLA readiness.
- Placement agent H.C. Wainwright received 7% cash fee plus warrants at $1.0625; board members and insiders participated.
- Company subject to 60-day equity issuance lock-up and one-year variable rate transaction ban.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1721484/000121390025074318/0001213900-25-074318-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1721484/000121390025074318/ea0252590-8k_longeveron.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-074318

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer